Supplemental Table 8. Distribution of LDL particle sizes (absolute values).
Baseline | Week 12 | |
---|---|---|
Cholesterol particle size of LDL, nm | ||
Placebo | 25.94 (25.61, 26.25) | 25.92 (25.60, 26.25) |
Evolocumab | 25.94 (25.71, 26.24) | 26.12 (25.81, 26.44) |
Change from baseline, % | ||
Placebo | 0.00 (−0.81, 0.78) | |
Evolocumab | 0.39 (−0.42, 1.24) |
Abbreviation: LDL, low-density lipoprotein. Data are expressed as median (1st quartile, 3rd quartile).